Dietary Supplement
Lactobacillus fermentum CECT5716
Lactobacillus fermentum CECT5716 is a dietary supplement with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Effect of Probiotics Consumed During Pregnancy on the Incidence of Mastitis
NCT04032899
completednot_applicable
Evaluation of Lactobacillus Fermentum CECT5716 on the Incidence of Mastitis
NCT02203877
completednot_applicable
L.Fermentum CECT5716 in Treatment of Breast Pain
NCT02093338
Clinical Trials (3)
Showing 3 of 3 trials
NCT04032899Not Applicable
Effect of Probiotics Consumed During Pregnancy on the Incidence of Mastitis
NCT02203877Not Applicable
Evaluation of Lactobacillus Fermentum CECT5716 on the Incidence of Mastitis
NCT02093338Not Applicable
L.Fermentum CECT5716 in Treatment of Breast Pain
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3